Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Evoke Pharma (EVOK) Interest Coverage Ratio (2020 - 2025)

Historic Interest Coverage Ratio for Evoke Pharma (EVOK) over the last 6 years, with Q3 2025 value amounting to 9.03.

  • Evoke Pharma's Interest Coverage Ratio rose 1150.92% to 9.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 10.38, marking a year-over-year increase of 1173.5%. This contributed to the annual value of 10.38 for FY2024, which is 3015.75% up from last year.
  • Latest data reveals that Evoke Pharma reported Interest Coverage Ratio of 9.03 as of Q3 2025, which was up 1150.92% from 12.51 recorded in Q2 2025.
  • Over the past 5 years, Evoke Pharma's Interest Coverage Ratio peaked at 9.03 during Q3 2025, and registered a low of 21.0 during Q1 2021.
  • Its 5-year average for Interest Coverage Ratio is 13.72, with a median of 13.57 in 2022.
  • In the last 5 years, Evoke Pharma's Interest Coverage Ratio surged by 9927.2% in 2021 and then crashed by 2740.18% in 2025.
  • Quarter analysis of 5 years shows Evoke Pharma's Interest Coverage Ratio stood at 12.28 in 2021, then decreased by 10.5% to 13.57 in 2022, then fell by 10.42% to 14.98 in 2023, then surged by 36.77% to 9.47 in 2024, then increased by 4.69% to 9.03 in 2025.
  • Its Interest Coverage Ratio was 9.03 in Q3 2025, compared to 12.51 in Q2 2025 and 10.56 in Q1 2025.